Page last updated: 2024-09-05

dabigatran and Brain Ischemia

dabigatran has been researched along with Brain Ischemia in 96 studies

Research

Studies (96)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (2.08)	29.6817
2010's	73 (76.04)	24.3611
2020's	21 (21.88)	2.80

Authors

Authors	Studies
Akhmatkhanova, LK; Cheboksarov, DV; Khamidova, LT; Klychnikova, EV; Kokov, LS; Kovaleva, EA; Muslimov, RS; Petrikov, SS; Ramazanov, GR; Rybalko, NV; Shamalov, NA	1
Archontakis-Barakakis, P; Batsidis, A; Giamouzis, G; Giannakoulas, G; Giannopoulos, S; Kalaitzoglou, D; Kokkinidis, DG; Li, W; Lip, GYH; Manolopoulos, A; Ntaios, G; Palaiodimos, L; Tzelves, L	1
Kalka, I; Kornowski, R; Rossman, H; Segal, E; Talmor-Barkan, Y; Witberg, G; Yacovzada, NS	1
Lee, B; Mahawish, KM; Shiu, S	1
Andreone, V; Anticoli, S; Barbarini, L; Biguzzi, S; Caggiula, M; Candelaresi, P; Caso, V; Cenciarelli, S; Colangeli, E; Concari, L; Cordici, F; De Angelis, MV; Dell'Aera, C; Diana, F; Digiovanni, A; Eusebi, P; Fortunata Musolino, R; Gentile, M; Giammello, F; Giannandrea, D; Giorli, E; La Gioia, S; Longoni, M; Mangiardi, M; Matteo, E; Migliaccio, L; Mosconi, MG; Muto, M; Naccarato, M; Paciaroni, M; Petruzzellis, M; Pronello, E; Ricci, S; Rizzo, F; Romoli, M; Ruggiero, M; Sacco, S; Scura, GM; Sepe, FN; Sessa, M; Toni, D; Zedde, ML; Zini, A	1
Lai, TH; Lai, YJ; Lin, YT	1
Goyal, N; Mowla, A; Sadighi, A; Seiffge, DJ; Shahjouei, S; Tsivgoulis, G; Wang, M; Zand, R	1
Abdalla, Y; Abraham, A; Althaus, K; Becks, G; Berrouschot, J; Berthel, J; Bode, FJ; Burghaus, L; Cangür, H; Daffertshofer, M; Diener, HC; Edelbusch, S; Eggers, J; El-Sabassy, H; Eschenfelder, CC; Gerlach, R; Grond, M; Gröschel, K; Große-Dresselhaus, F; Günther, A; Haase, CG; Haensch, CA; Harloff, A; Heckmann, JG; Held, V; Hieber, M; Kauert, A; Kermer, P; Kern, R; Kerz, T; Köhrmann, M; Kraft, P; Kühnlein, P; Latta, J; Leinisch, E; Leithner, C; Lenz, A; Mäurer, M; Müllges, W; Neumann-Haefelin, T; Nolte, CH; Obermann, M; Partowi, S; Patzschke, P; Poli, S; Pulkowski, U; Purrucker, J; Rehfeldt, T; Ringleb, PA; Rossi, R; Röther, J; Sarnowksi, BV; Sauer, O; Schackert, G; Schäfer, N; Schellinger, PD; Schneider, A; Schuppner, R; Schwab, S; Schwarte, O; Seitz, RJ; Senger, S; Shah, YP; Sindern, E; Sparenberg, P; Steiner, T; Szabo, K; Urbanek, C; Weissenborn, K; Wienecke, P; Witt, K; Wruck, R; Wunderlich, S	1
Huang, Y; Liang, H; Rong, G; Wang, H; Wang, L	1
Chaturvedi, S; Mehndiratta, P	1
Benavente, OR; Buck, B; Butcher, KS; Coutts, SB; Field, TS; Gioia, LC; Hart, RG; Hill, MD; Klahr, AC; Miller, J; Ng, K; Sharma, M; Sheridan, P; Siddiqui, M; Sivakumar, L	1
Božič-Mijovski, M; Detkova, N; Frol, S; Gradišek, P; Gregorič, M; Kosi, IE; Mavri, A; Nedog, V; Stecher, A; Uštar, KK; Vene, N; Žerjav, U	1
Beharry, J; Campbell, BCV; Drew, R; Fink, JN; Kleinig, TJ; Parsons, MW; Waters, MJ; Wilson, D; Wu, TY	1
Ashley, J; Badve, SV; Battistella, M; Bota, S; Garg, AX; Harel, Z; Jun, M; Manuel, D; Mavrakanas, T; McArthur, E; Molnar, AO; Rhodes, E; Sood, MM; Tanuseputro, P; Wells, P	1
Alrohimi, A; Buck, B; Butcher, K; Dowlatshahi, D; Kalashyan, H; Ng, K; Shamy, M; Sharma, M; Shuaib, A; Sivakumar, L; Stotts, G; Thirunavukkarasu, S	1
Ahmed, N; Barbarini, L; Escudero-Martinez, I; Fryze, W; Gdovinova, Z; Karlinski, M; Kobayashi, A; Krastev, G; Lesko, N; Mazya, M; Paiva Nunes, A; Pasztoova, K; Peeters, A; Sobolewski, P; Teutsch, C; Toni, D; Vilionskis, A	1
García-Sempere, A; Hurtado, I; Peiró, S; Rodríguez-Bernal, CL; Sanfélix-Gimeno, G; Santa-Ana-Téllez, Y	1
Chan, EW; Chan, KWK; Chen, JY; Choi, CW; Fan, K; Feng, Y; Hai, JJ; Huang, D; Jim, MH; Lam, CC; Lam, H; Lau, YM; Lee, KL; Ng, A; Siu, CW; Tam, CCF; Tan, N; Wong, CK; Wong, YTA; Yan, BP; Yiu, KH; Yung, CY; Yung, SYA; Zhou, M	1
Ahn, SH; Cho, HJ; Choi, HY; Choi, JK; Han, SW; Heo, JH; Jung, YH; Kang, YJ; Kim, WJ; Kim, YD; Kwon, JH; Lee, KY; Nam, HS; Park, HJ; Park, JH; Seo, JH; Sung, SM	1
Carney, G; Durand, M; Eltonsy, S; Filion, KB; Fisher, A; Jun, M; Kuo, IF; Matteau, A; Pang, M; Paterson, JM; Quail, J; Renoux, C; Schnitzer, ME	1
Akpan, IJ; Cuker, A	1
Bhave, PD; Chrischilles, E; Girotra, S; Giudici, M; Hodgson-Zingman, D; Mazur, A; Palamaner Subash Shantha, G; Vaughan Sarrazin, MS	1
He, J; Nordling, MM; Tireli, D; Wienecke, T	1
Abdalla, Y; Althaus, K; Berrouschot, J; Cangür, H; Daffertshofer, M; Diener, HC; Edelbusch, S; Eschenfelder, CC; Grond, M; Gröschel, K; Haase, CG; Harloff, A; Held, V; Kauert, A; Kermer, P; Kraft, P; Lenz, A; Müllges, W; Obermann, M; Partowi, S; Purrucker, J; Ringleb, PA; Rossi, R; Röther, J; Schäfer, N; Schneider, A; Schuppner, R; Seitz, RJ; Szabo, K; Wruck, R	1
Lip, GYH; Makaritsis, K; Michel, P; Ntaios, G; Papavasileiou, V; Vemmos, K	1
Agosti, S; Casalino, L; Rocci, E; Rota, E; Zaccone, G	1
Golaszewski, SM; Pikija, S; Sebastian Mutzenbach, J; Sellner, J; Sztriha, LK	1
Abdul-Rahim, AH; Acampa, M; Acciarresi, M; Ageno, W; Agnelli, G; Alberti, A; Athanasakis, G; Bandini, F; Becattini, C; Bellesini, M; Bono, G; Bovi, P; Cappellari, M; Carletti, M; Carolei, A; Caso, V; Chiti, A; Chondrogianni, M; Ciccone, A; Cimini, LA; Colombo, G; Consoli, D; Corea, F; D'Amore, C; De Lodovici, ML; Denti, L; Falocci, N; Flomin, Y; Furie, KL; Galati, F; Gialdini, G; Giannini, N; Giorli, E; Giuntini, M; Gourbali, V; Guideri, F; Karagkiozi, E; Karapanayiotides, T; Kargiotis, O; Lanari, A; Lees, KR; Letteri, F; Liantinioti, C; Lorenzini, G; Lotti, EM; Maccarrone, M; Maimone Baronello, M; Makaritsis, K; Mancuso, M; Marcheselli, S; Martini, G; Masotti, L; Monaco, S; Mosconi, MG; Mumoli, N; Ntaios, G; Orlandi, G; Paciaroni, M; Padovani, A; Pezzini, A; Poli, L; Putaala, J; Sacco, S; Scoditti, U; Silvestrelli, G; Sohn, SI; Soloperto, R; Tadi, P; Tassi, R; Tassinari, T; Tatlisumak, T; Tiseo, C; Tomppo, L; Toni, D; Tsivgoulis, G; Vadikolias, K; Vannucchi, V; Venti, M; Yaghi, S; Zedde, M	1
Ishikawa, T; Moroi, J; Nakase, T	1
De Maistre, E; Derex, L; Gouin-Thibault, I; Gruel, Y; Sie, P; Susen, S; Touzé, E	1
Jesus, PAP; Monteiro, JMC; Oliveira Filho, J; San-Martin, DL; Silva, BCG	1
Choudhry, NK; Gagne, JJ; Najafzadeh, M; Schneeweiss, S; Wang, SV	1
Escobar, C; Martí-Almor, J; Martínez-Zapata, MJ; Pérez Cabeza, A	1
Fang, CW; Hsiao, YJ; Lin, FY; Lu, CH; Tsai, LK; Tsai, YT; Yen, PS	1
Banach, M; Covic, A; Lopatowska, P; Malyszko, J; Mlodawska, E; Sobkowicz, B; Tomaszuk-Kazberuk, A	1
Černík, D; Herzig, R; Jakubíček, S; Kunáš, Z; Mikulík, R; Ostrý, S; Reif, M; Rohan, V; Šaňák, D; Tomek, A; Veverka, T	1
Bereczki, D; May, Z; Pásztor, M; Szakács, Z	1
Campbell, BC; Coote, S; Davis, SM; Donnan, GA; Easton, D; Jones, B; Ng, F; Ng, JL; Parsons, M; Pesavento, L; Rodrigues, E; Yan, B; Zhao, H	1
Fang, CW; Hsiao, YJ; Tsai, LK; Tsai, YT	1
Bhatt, DL; Federspiel, JJ; Fonarow, GC; Hernandez, AF; Huang, RJ; Jin, C; Laskowitz, DT; Peterson, ED; Schwamm, LH; Smith, EE; Xian, Y	1
Andersen, M; Braunschweig, F; Forslund, T; Hjemdahl, P; Komen, JJ; Mantel-Teeuwisse, AK; von Euler, M; Wettermark, B	1
Dei, A; Grifoni, E; Landini, G; Masotti, L; Moroni, F; Panigada, G; Spolveri, S; Vannucchi, V	1
Frol, S; Pretnar Oblak, J; Sabovic, M	1
Cowperthwaite, M; Fanale, C; Nadasdy, Z; Ramakrishnan, A; Shpak, M	1
Breuer, L; Engelhorn, T; Kallmünzer, B; Macha, K; Marsch, A; Schwab, S; Siedler, G; Strasser, EF	1
Herkes, G; Loh, CH	1
Dieterich, M; Dietrich, D; Feil, K; Feuerecker, R; Jandl, M; Kellert, L; Klein, M; Küpper, C; Lücking, M; Marziniak, M; Poppert, H; Thanbichler, F; Topka, H; Wunderlich, S; Zerkaulen, I	1
Bereczki, D; Béres-Molnár, KA; Folyovich, A; Vadasdi, K; Varga, V	1
Chen, JH; Connolly, SJ; Dans, AL; Ezekowitz, MD; Hori, M; Kim, SS; Koyanagi, M; Lau, CP; Liu, LS; Omar, R; Pais, P; Reilly, PA; Tan, RS; Tanomsup, S; Wallentin, L; Watanabe, M; Xavier, D; Yusuf, S; Zhu, J	1
Bosnyák, E; Csécsei, P; Deli, G; Fehér, G; Szapary, L	1
Eder, V; Haring, HP; Müller, P; Nesser, HJ; Nußbaumer, K; Sonnberger, M; Topakian, R; Trenkler, J; Windpessl, M	1
Abe, K; Deguchi, K; Ikeda, Y; Kono, S; Kurata, T; Omote, Y; Yamashita, T; Yunoki, T	1
Bastovansky, A; Finsterer, J; Paul, G; Stöllberger, C	1
Butcher, K; Kate, M; Shuaib, A; Szkotak, A; Witt, A	1
Aburakawa, Y; Kimura, T; Kuroda, K; Suzuki, Y; Yahara, O; Yoshida, K	1
Foley, J; Kirchhof, P; Lip, GY	1
Aslan, O; Ozdemir, M; Senol, H; Ugur-Yildiz, M; Yaylali, YT; Yildirim, S; Yurtdas, M	1
Alonso Cánovas, A; Cruz, A; DeFelipe-Mimbrera, A; Guillán, M; Masjuan, J; Matute, C; Sainz de la Maza, S; Vera, R	1
Bnouhanna, W; Cho, TH; Davenas, C; Derex, L; Farghali, A; Mechtouff, L; Nighoghossian, N; Ritzenthaler, T	1
Cattaneo, M; Lussana, F; Squizzato, A	1
Buck, B; Butcher, K; Gioia, L; Jeerakathil, T; Kate, M; Shuaib, A; Sivakumar, L	1
Angelopoulou, SM; Bouziana, SD; Giampatzis, V; Hatzitolios, AI; Konstantara, F; Kostaki, S; Papadopoulou, M; Savopoulos, C; Spanou, M; Tziomalos, K	1
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP	1
Chan, EW; Chan, PH; Chiang, CE; Hai, JJ; Huang, D; Lau, CP; Li, WH; Siu, CW; Tse, HF; Wong, IC; Yin, LX; Zhu, J	1
Collins, J; Fraeman, K; Reynolds, MW; Schnee, J; Schwartzman, E; Siu, K; Villines, TC	1
Bartels, DB; Bykov, K; Huybrechts, K; Schneeweiss, S; Seeger, JD; Zint, K	1
Brueckmann, M; Clemens, A; Kreuzer, J; Liesenfeld, KH; Schulze, F	1
Barnes, GD; Froehlich, JB; Hutton, DW; Levine, DA; Salata, BM	1
Barake, W; Baranchuk, A; Chu, K; Lamb, T; Lamba, J; Marr, JN; McIntyre, WF; Mohajer, K; Oqab, Z; Quadros, K; Quinn, KL; van Oosten, E; Yazdan-Ashoori, P	1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC	1
Hayes, CJ; Martin, BC; Shah, A; Shewale, A	1
Aoyagi, H; Asano, M; Hirao, K; Kawaguchi, N; Kurabayashi, M; Nakamura, T; Okishige, K; Sasano, T; Shimura, T; Suzuki, H; Yamashita, M; Yamauchi, Y	1
Müller, A; Schäfer, N; Wüllner, U	1
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A	1
Bernstein, R; Butcher, K; Campbell, B; Cloud, G; Davalos, A; Davis, S; Diener, HC; Ferro, JM; Grond, M; Krieger, D; Ntaios, G; Slowik, A; Touzé, E	1
Bonde, AN; Fosbøl, EL; Gerds, TA; Gislason, GH; Lamberts, M; Lip, GYH; Olesen, JB; Ozenne, B; Staerk, L; Torp-Pedersen, C	1
Kreps, B; Schulz, JG	1
Chan, EW; Chan, PH; Chiang, CE; Huang, D; Lau, CP; Li, WH; Lip, GYH; Siu, CW; Tse, HF; Wong, ICK	1
Bice, J; Crompton, DE; Lee-Archer, M; Ng, FC; Rodda, A	1
Terayama, Y	1
Chan, L	1
Gil Núñez, A	2
Qureshi, AI; Siddiqui, FM; Watanabe, M	1
Nagatani, K; Nawashiro, H; Osada, H; Otani, N; Takeuchi, S; Wada, K	1
Fong, A; Hanley, D; Lynch, D; Sani, Y; Schevchuck, A; Serebruany, V; Svetlov, S; Thevathasan, L	1
Diener, HC; Eikelboom, J; Granger, CB; Hacke, W	1
Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Heidbuchle, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S	1
Finsterer, J; Rakusan, S; Stöllberger, C; Wimpissinger, FT	1
Gliem, M; Hartung, HP; Hermsen, D; Jander, S; van Rooijen, N	1
Kanorsky, SG; Shevelev, VI	1
Grove, EL; Husted, SE; Kraglund, KL; Modrau, B	1
Alvarez, M; de Gea-García, JH; Jiménez-Parra, JD; Ruiz-Villa, G	1
Re, G; Toni, D	1
Mungall, D	1
Eikelboom, JW; Hirsh, J; O'Donnell, M	1

Reviews

17 review(s) available for dabigatran and Brain Ischemia

Article	Year
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies. British journal of clinical pharmacology, 2022, Volume: 88, Issue:11 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Humans; Intracranial Hemorrhages; Ischemic Stroke; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2022
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis. European stroke journal, 2023, Volume: 8, Issue:1 Topics: Anticoagulants; Antithrombins; Brain Ischemia; Dabigatran; Humans; Intracranial Hemorrhages; Ischemic Stroke; Multicenter Studies as Topic; Observational Studies as Topic; Stroke; Thrombolytic Therapy	2023
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis. Stroke, 2020, Volume: 51, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Middle Aged; Risk Factors; Stroke; Warfarin	2020
Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis. British journal of clinical pharmacology, 2021, Volume: 87, Issue:6 Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Humans; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin	2021
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke, 2017, Volume: 48, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Myocardial Infarction; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin	2017
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence. CNS drugs, 2017, Volume: 31, Issue:9 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Female; Hemorrhage; Humans; Male; Practice Guidelines as Topic; Stroke; Tissue Plasminogen Activator	2017
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis. Revista espanola de cardiologia (English ed.), 2019, Volume: 72, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Case-Control Studies; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Observational Studies as Topic; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Treatment Outcome; Vitamin K; Warfarin	2019
Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants? International urology and nephrology, 2018, Volume: 50, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Humans; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles	2018
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke. Stroke, 2018, Volume: 49, Issue:9 Topics: Administration, Intravenous; Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Brain Ischemia; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Odds Ratio; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Tissue Plasminogen Activator	2018
[Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran]. Ideggyogyaszati szemle, 2013, May-30, Volume: 66, Issue:5-6 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Intracranial Hemorrhages; Pyridines; Risk Assessment; Risk Factors; Stroke; Vitamin K	2013
Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all? Current vascular pharmacology, 2014, Volume: 12, Issue:3 Topics: Administration, Oral; Age Factors; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Morpholines; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiophenes	2014
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty. Thrombosis and haemostasis, 2015, Volume: 114, Issue:2 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2015
Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment. Neurocritical care, 2012, Volume: 16, Issue:1 Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Incidence; Pyridines; Stroke; Thrombin	2012
[Prevention of cardioembolic stroke]. Neurologia (Barcelona, Spain), 2012, Volume: 27 Suppl 1 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fibrinolytic Agents; Heart Diseases; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Multicenter Studies as Topic; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Single-Blind Method; Thrombophilia; Vitamin K	2012
[Anticoagulant therapy in stroke patients]. Ugeskrift for laeger, 2013, Jan-28, Volume: 175, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Radiography; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K	2013
BIBR-1048 Boehringer Ingelheim. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:6 Topics: Animals; Benzimidazoles; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Prodrugs; Pyridines; Structure-Activity Relationship; Thromboembolism; Venous Thrombosis	2002
Beyond unfractionated heparin and warfarin: current and future advances. Circulation, 2007, Jul-31, Volume: 116, Issue:5 Topics: Angina, Unstable; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Brain Ischemia; Clinical Trials as Topic; Coumarins; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Morpholines; Myocardial Infarction; Peptide Fragments; Polysaccharides; Prothrombin; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Thrombosis; Warfarin	2007

Trials

5 trial(s) available for dabigatran and Brain Ischemia

Article	Year
Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke, 2020, Volume: 51, Issue:4 Topics: Aged; Antithrombins; Brain Ischemia; Dabigatran; Female; Humans; Male; Middle Aged; Prospective Studies; Single-Blind Method; Stroke; Treatment Outcome	2020
Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study. BMJ open, 2020, 09-25, Volume: 10, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Hong Kong; Humans; Mitral Valve Stenosis; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2020
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke, 2013, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asia; Asian People; Atrial Fibrillation; Benzimidazoles; Brain Ischemia; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyridines; Stroke; Warfarin	2013
Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2016, Volume: 22, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Dabigatran; Female; Humans; Male; Middle Aged; Stroke; Turkey; Warfarin	2016
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation, 2012, Jul-17, Volume: 126, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Brain Ischemia; Cardiac Pacing, Artificial; Cataract Extraction; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Risk Factors; Stroke; Thromboembolism; Warfarin	2012

Other Studies

74 other study(ies) available for dabigatran and Brain Ischemia

Article	Year
[First case of thrombolysis with non-immunogenic staphylokinase in a patient with ischemic stroke receiving dabigatran etexilate followed by thrombectomy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:6 Topics: Anticoagulants; Brain Ischemia; Dabigatran; Fibrinolytic Agents; Humans; Ischemic Stroke; Metalloendopeptidases; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2022
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial. European heart journal. Cardiovascular pharmacotherapy, 2022, 12-15, Volume: 9, Issue:1 Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Rivaroxaban; Stroke	2022
Stroke thrombolysis in a patient on dabigatran in the extended time window. The New Zealand medical journal, 2022, Jan-20, Volume: 136, Issue:1568 Topics: Antithrombins; Brain Ischemia; Dabigatran; Humans; New Zealand; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2022
Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report. The Journal of emergency medicine, 2020, Volume: 58, Issue:3 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Brain Ischemia; Dabigatran; Humans; Male; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2020
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases. International journal of stroke : official journal of the International Stroke Society, 2020, Volume: 15, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Germany; Humans; Intracranial Hemorrhages; Ischemic Stroke; Retrospective Studies; Stroke; Thrombolytic Therapy	2020
Persistence, effectiveness and safety of dabigatran in "real-world" Chinese patients with nonvalvular atrial fibrillation. Heart and vessels, 2020, Volume: 35, Issue:7 Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Brain Ischemia; China; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Stroke; Time Factors; Treatment Outcome	2020
Early Anticoagulation for Minor Non-Cardioembolic Stroke and Transient Ischemic Attack: Too Early to Call. Stroke, 2020, Volume: 51, Issue:4 Topics: Anticoagulants; Brain Ischemia; Dabigatran; Humans; Ischemic Attack, Transient; Stroke	2020
Idarucizumab for dabigatran reversal in daily clinical practice: A case series. European journal of anaesthesiology, 2020, Volume: 37, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Brain Ischemia; Dabigatran; Humans; Stroke	2020
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke. Stroke, 2020, Volume: 51, Issue:5 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Australia; Brain Ischemia; Dabigatran; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; New Zealand; Stroke; Tenecteplase; Thrombectomy; Thrombolytic Therapy	2020
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Antithrombins; Brain Ischemia; Cause of Death; Comorbidity; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Myocardial Revascularization; Ontario; Procedures and Techniques Utilization; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Rivaroxaban; Thrombophilia; Vitamin K	2020
Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:5 Topics: Aged; Aged, 80 and over; Brain Ischemia; Dabigatran; Humans; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Prospective Studies; Stroke; Treatment Outcome; United States	2020
Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry. BMJ open, 2020, 05-19, Volume: 10, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Female; Humans; Ischemic Stroke; Male; Registries; Retrospective Studies; Stroke	2020
Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population-based propensity-weighted cohort study. British journal of clinical pharmacology, 2021, Volume: 87, Issue:2 Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Humans; India; Netherlands; Retrospective Studies; Rivaroxaban; Spain; Stroke	2021
Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests. PloS one, 2020, Volume: 15, Issue:10 Topics: Acute Disease; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prognosis; Prothrombin Time; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Stroke	2020
Laboratory assessment of the direct oral anticoagulants: who can benefit? Kardiologia polska, 2021, Volume: 79, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Humans; Laboratories; Pyridones; Rivaroxaban; Stroke	2021
Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes, 2017, Volume: 10, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Chi-Square Distribution; Comparative Effectiveness Research; Dabigatran; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Medicare Part D; Multivariate Analysis; Patient Admission; Propensity Score; Proportional Hazards Models; Protective Factors; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Sex Factors; Stroke; Treatment Outcome; United States; Warfarin	2017
Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:7 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Brain Ischemia; Dabigatran; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Perfusion Imaging; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome	2017
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection. International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:4 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Female; Germany; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2017
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report. Journal of medical case reports, 2017, Aug-15, Volume: 11, Issue:1 Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Interactions; Female; Humans; Hypertension; Stroke; Thrombolytic Therapy; Treatment Outcome	2017
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study. Journal of the American Heart Association, 2017, Nov-29, Volume: 6, Issue:12 Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Survival Rate; Time Factors; Treatment Outcome; Vitamin K	2017
Outcome of Secondary Stroke Prevention in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Dabigatran; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrazoles; Pyridones; Recurrence; Risk Factors; Rivaroxaban; Secondary Prevention; Stroke; Time Factors; Treatment Outcome; Warfarin	2018
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants. European journal of neurology, 2018, Volume: 25, Issue:5 Topics: Administration, Intravenous; Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation Tests; Brain Ischemia; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Retrospective Studies; Rivaroxaban; Stroke; Thrombolytic Therapy	2018
Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke. Arquivos de neuro-psiquiatria, 2018, Volume: 76, Issue:1 Topics: Aged; Anticoagulants; Brain Ischemia; Chagas Cardiomyopathy; Dabigatran; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Retrospective Studies; Stroke; Warfarin	2018
Simulation for Predicting Effectiveness and Safety of New Cardiovascular Drugs in Routine Care Populations. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:5 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Brain Ischemia; Computer Simulation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Models, Biological; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin	2018
Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation. Journal of the neurological sciences, 2018, 05-15, Volume: 388 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Fatal Outcome; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy	2018
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:9 Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Recombinant Proteins; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2018
[Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke]. Ideggyogyaszati szemle, 2017, Jul-30, Volume: 70, Issue:7-8 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Brain Ischemia; Dabigatran; Fibrinolytic Agents; Humans; Stroke; Thrombolytic Therapy	2017
Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit. International journal of stroke : official journal of the International Stroke Society, 2019, Volume: 14, Issue:3 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Ambulances; Antibodies, Monoclonal, Humanized; Australia; Brain Ischemia; Dabigatran; Emergency Medical Services; Feasibility Studies; Female; Humans; Male; Stroke; Thrombolytic Therapy	2019
Idarucizumab-facilitated intravenous thrombolysis in acute ischemic stroke: A therapeutic strategy requiring further investigation. Journal of the neurological sciences, 2018, 11-15, Volume: 394 Topics: Antibodies, Monoclonal, Humanized; Brain Ischemia; Clinical Trials as Topic; Dabigatran; Humans; Stroke; Thrombolytic Therapy	2018
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants. Stroke, 2018, Volume: 49, Issue:9 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin	2018
Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence. Thrombosis research, 2018, Volume: 172 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Female; Hemorrhage; Humans; Male; Prognosis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiazoles	2018
Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis? Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:3 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Blood Coagulation; Brain Ischemia; Dabigatran; Disability Evaluation; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Recovery of Function; Retrospective Studies; Severity of Illness Index; Slovenia; Stroke; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome	2019
Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants. Stroke, 2018, Volume: 49, Issue:12 Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Female; Humans; Incidence; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin	2018
Cerebral Ischemia in Patients on Direct Oral Anticoagulants. Stroke, 2019, Volume: 50, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Female; Humans; Male; Middle Aged; Registries; Rivaroxaban; Severity of Illness Index; Stroke; Warfarin	2019
Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab. BMJ case reports, 2019, May-05, Volume: 12, Issue:5 Topics: Aged; Antibodies, Monoclonal, Humanized; Brain Ischemia; Dabigatran; Humans; Male; Stroke; Thrombolytic Therapy; Tomography, X-Ray Computed; Treatment Outcome	2019
Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa® in clinical routine (MR REPAIR). Journal of neurology, 2019, Volume: 266, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Brain Ischemia; Dabigatran; Emergency Medical Services; Germany; Hemorrhage; Humans; Registries; Stroke	2019
Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:3 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Brain Ischemia; Contraindications; Dabigatran; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Middle Aged; Partial Thromboplastin Time; Patient Selection; Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke; Thrombin Time; Thrombolytic Therapy; Time Factors; Treatment Outcome	2014
Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10 Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Angiography; Dabigatran; Endovascular Procedures; Female; Heart Failure; Humans; Paresis; Stroke; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome	2013
Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat. Journal of neuroscience research, 2014, Volume: 92, Issue:1 Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Disease Models, Animal; Fibrinolytic Agents; Intracranial Hemorrhages; Male; Rats; Rats, Wistar; Stroke; Tissue Plasminogen Activator; Warfarin	2014
Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy. Cardiovascular therapeutics, 2013, Volume: 31, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Stroke	2013
Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Brain Ischemia; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Partial Thromboplastin Time; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2014
Recurrent ischemic stroke in a patient with the Trousseau syndrome treated with dabigatran. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:6 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Male; Recurrence; Stroke	2014
Dabigatran in secondary stroke prevention: clinical experience with 106 patients. BioMed research international, 2014, Volume: 2014 Topics: Aged; Aged, 80 and over; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Stroke	2014
Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke. Revue neurologique, 2015, Volume: 171, Issue:8-9 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Length of Stay; Male; Pilot Projects; Radiography; Recombinant Proteins; Recurrence; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator	2015
Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation. Stroke, 2015, Volume: 46, Issue:9 Topics: Aged; Antithrombins; Brain Ischemia; Dabigatran; Feasibility Studies; Female; Humans; Male; Middle Aged; Stroke; Time Factors; Treatment Outcome	2015
Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2 Topics: Acenocoumarol; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Female; Humans; Male; Myocardial Infarction; Patient Discharge; Prospective Studies; Stroke; Survival Analysis; Thrombosis	2016
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin	2015
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation. Heart rhythm, 2016, Volume: 13, Issue:2 Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; China; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Outcome Assessment, Health Care; Stroke; Warfarin	2016
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Disease-Free Survival; Drug Evaluation; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Insurance Coverage; Kaplan-Meier Estimate; Male; Middle Aged; Military Personnel; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Evaluation; Embolism; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Insurance Coverage; Male; Middle Aged; Myocardial Infarction; Polypharmacy; Propensity Score; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Dabigatran treatment simulation in patients undergoing maintenance haemodialysis. Thrombosis and haemostasis, 2016, Volume: 115, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Area Under Curve; Atrial Fibrillation; Brain Ischemia; Computer Simulation; Dabigatran; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Stroke; Vitamin K	2016
Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation. The American journal of cardiology, 2016, Jan-01, Volume: 117, Issue:1 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Brain Ischemia; Cost-Benefit Analysis; Dabigatran; Dose-Response Relationship, Drug; Drug Costs; Female; Health Expenditures; Humans; Male; Retrospective Studies; United States; Warfarin	2016
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation. The Canadian journal of cardiology, 2016, Volume: 32, Issue:6 Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Canada; Dabigatran; Female; Guidelines as Topic; Humans; Internship and Residency; Male; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Surveys and Questionnaires; Treatment Outcome; Universities; Warfarin	2016
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Stroke, 2016, Volume: 47, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin	2016
Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke, 2016, Volume: 47, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cost-Benefit Analysis; Dabigatran; Humans; Insurance, Health; Middle Aged; Models, Theoretical; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Risk; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles; Warfarin	2016
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation. Journal of cardiology, 2017, Volume: 69, Issue:1 Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain; Brain Ischemia; Cryosurgery; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin	2017
Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:8 Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Female; Humans; Stroke; Tomography Scanners, X-Ray Computed	2016
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab. Stroke, 2016, Volume: 47, Issue:7 Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator	2016
Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion. International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:1 Topics: Antithrombins; Brain Ischemia; Dabigatran; Humans; Stroke; Thrombectomy; Thrombolytic Therapy	2017
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. European heart journal, 2017, Mar-21, Volume: 38, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Denmark; Female; Hospitalization; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Vitamin K; Warfarin	2017
Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke. Journal of the neurological sciences, 2016, 11-15, Volume: 370 Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Clinical Trials as Topic; Coagulants; Dabigatran; Female; Humans; Stroke; Thrombolytic Therapy	2016
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. Clinical cardiology, 2017, Volume: 40, Issue:4 Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hong Kong; Humans; Incidence; Male; Retrospective Studies; Rivaroxaban; Survival Rate; Time Factors; Treatment Outcome; Warfarin	2017
Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis. Journal of neurology, 2017, Volume: 264, Issue:3 Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Brain Ischemia; Dabigatran; Fatal Outcome; Humans; Male; Middle Aged; Stroke; Thrombolytic Therapy	2017
Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2017, Volume: 26, Issue:6 Topics: Administration, Oral; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antithrombins; Blood Coagulation; Brain Ischemia; Dabigatran; Databases, Factual; Drug Approval; Factor Xa Inhibitors; Female; Humans; Incidence; Intracranial Hemorrhages; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Time Factors; Treatment Outcome	2017
Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke? Archives of neurology, 2010, Volume: 67, Issue:9 Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Pyridines; Stroke; Tissue Plasminogen Activator	2010
[Advances in the prevention of cerebral ischaemia due to atrial fibrillation]. Neurologia (Barcelona, Spain), 2010, Volume: 25, Issue:7 Topics: Amiodarone; Anticoagulants; Antifibrinolytic Agents; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Diagnosis, Differential; Dronedarone; Humans; Vitamin K	2010
Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients. Acta neurochirurgica, 2012, Volume: 154, Issue:1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Fibrinolytic Agents; Humans; Injections, Intravenous; Risk Factors; Stroke; Tissue Plasminogen Activator	2012
Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke. Journal of thrombosis and thrombolysis, 2012, Volume: 33, Issue:1 Topics: Aged; Automation; Benzimidazoles; beta-Alanine; Biomarkers; Brain Ischemia; Calibration; Dabigatran; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Radiography; Stroke; Thrombin	2012
The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War? International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:2 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Thrombin; Warfarin	2012
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bone Neoplasms; Brain Ischemia; Comorbidity; Dabigatran; Hematuria; Humans; Kidney Failure, Chronic; Leuprolide; Male; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Thrombophilia; Urinary Retention	2012
Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice. Stroke, 2012, Volume: 43, Issue:12 Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Blood Coagulation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Intracranial Embolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenprocoumon; Pyridines; Risk Factors; Stroke; Time Factors	2012
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:10 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin	2012
[Wünderlich syndrome in patient anticoagulated with dabigatran]. Medicina clinica, 2013, Aug-17, Volume: 141, Issue:4 Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Carcinoma, Transitional Cell; Dabigatran; Diabetes Mellitus, Type 2; Hematoma; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Nephrectomy; Pulmonary Disease, Chronic Obstructive; Retroperitoneal Space; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
Thrombolysis in ischemic stroke patients on treatment with Dabigatran. Internal and emergency medicine, 2013, Volume: 8, Issue:5 Topics: Antithrombins; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Humans; Stroke; Thrombolytic Therapy	2013